This study was stopped because of insufficient enrollment.
Fetal Fibronectin (fFN) and Salivary Estriol (E3) in the Prediction of Preterm Birth in Women With Twin Pregnancies Receiving 17-Alpha-Hydroxyprogesterone Caproate or Placebo
Sponsor study identifier
observational
0
1 country
2
Study Start
August 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2006
Actual (reported)Study Completion
February 2006
Actual (reported)Among women with a twin pregnancy, currently enrolled in a study in which they are receiving weekly injections of 17-alpha-hydroxyprogesterone caproate verses placebo injections, fetal fibronectin (fFN) and salivary estriol (E3 ) will identify the following.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2006
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2005
Date type not reportedThis date has not been verified as actual or estimated.
September 8, 2005
Actual (reported)September 12, 2005
Actual (reported)February 2006
Actual (reported)February 2006
Actual (reported)fFN test done during pregnancy
Salivary Estriol done during pregnancy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pregnant women (Twins or Triplets) already enrolled in the Obstetrix Clinical Trial " Progesterone for prevention of PTB in twin and triplet pregnancies"
Desert Good Samaritan Hospital
Mesa, Arizona, 85202, United States
Banner Good Sammaritan Hospital
Phoenix, Arizona, 85006, United States
Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol. 1996 May;87(5 Pt 1):643-8. doi: 10.1016/0029-7844(96)00035-x.
Darne J, McGarrigle HH, Lachelin GC. Increased saliva oestriol to progesterone ratio before preterm delivery: a possible predictor for preterm labor? Br Med J (Clin Res Ed). 1987 Jan 31;294(6567):270-2. doi: 10.1136/bmj.294.6567.270.
Kimberly Maurel, RN, MSN, CNS
Obstetrix Medical Group, Inc.
Richard Lee
Obstetrix Medical Group, Inc.
0 participants (actual enrollment reported by the registry).
First Submitted
September 8, 2005
First Posted
September 12, 2005
Study Start
August 2005
Date type not reportedThis date has not been verified as actual or estimated.
The Use of Progesterone to Reduce Preterm Birth
Contact the study team to confirm eligibility.
Primary Completion
February 2006
Actual (reported)Study Completion
February 2006
Actual (reported)Last Updated
December 19, 2014
Record last verified: 2014-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: